Martin Heitmann PhD

Martin Heitmann is senior scientist in the department Cell Culture Technology at Novo Nordisk A/S. The three main focus areas in the department are cell line evaluation, production of the first protein for non-clinical testing in animal models to obtain proof of concept and early process development for production of protein in mammalian cells. Since joining Novo Nordisk in 2011 Martin has focused on the development of scale-down tools for perfusion cultures as well as integrating perfusion cultivations and continuous purification for the production of complex proteins. Furthermore, Martin has previous experience in metabolome analysis of mammalian cells as well as downstream processing.